DECEMBER 2021LIFE SCIENCES REVIEW6Today, the Biotech space is adopting newer trends each day with breakthrough products and technologies to combat even the most debilitating and rarest of diseases. Consequently, there has been an increase in consumer Biotech or BioTech products targeted directly at customers instead of the healthcare or biopharma businesses. Case in point, despite the industry focusing solely on medicines, the emerging startups are working towards devising solutions that range from food and materials to environmental monitoring. In addition, the COVID-19 pandemic has further heightened the far-reaching impact of the BioTech industry with startups and firms developing innovative rapid testing kits, repurposed drugs, and vaccines.In present days, Artificial Intelligence has turned out to be yet another promising avenue, enabling startups to automate a wide array of processes and assist in scaling up their operations. For example, biopharma startups are leveraging AI to accelerate the drug discovery process, screening biomarkers as well as scraping through the scientific literature for discovering novel products. In addition to this, Big Data and analytics solutions are paving the way for innovatively managing the unprecedented amount of BioTechnology data. These technological developments enable biopharma companies to recruit patients for clinical trials efficiently with the ever-growing omics technologies and fusion of IoT sensors and devices. BioTech solutions are also showcasing the immense potential to bring in precision medicine to improve the overall quality of life. The declining costs of gene editing and gene sequencing are leading to better applications in clinical practices that are, in turn, enabling precision medicine. As a result, physicians are more efficiently determining the best-matched treatment and prevention methodologies for specific groups. Additionally, patients can benefit from personalized treatments for rare and critical diseases, including cancers, with the biotech startups leveraging precision medicine to identify new drug targets, novel drugs, and innovative gene therapies. These concurrent Biotech trends are rapidly accelerating research in biomanufacturing, bioprinting, precision medicine, and several other applications. The organizations are gradually adopting Industry 4.0 technologies that are simultaneously allowing the benefits to percolate into other industries such as pharma. At present, Biotech has become essential for long-term sustainability, offering eco-friendly alternatives to the production of materials and food and encouraging a circular economy by utilizing biomass feedstocks. On this note, Life Science Review has compiled its current edition on BioTech Startups in Europe to offer valuable insights into the trending solutions and strategies n the market.EDITORIALEnhancing Social Benefits with the Innovative BioTech Trends Copyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com December - 9 - 2021 02, Issue - 12 Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizers*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsSalesStephen Thomassales@lifesciencesreview.comDean WinchesterJohn Gotham
< Page 5 | Page 7 >